Company intelligence / Profile preview

Ovalt

Cambridge, England, United Kingdomgroupe-ovalt.com ↗

Ownership: Private
Development stage: Commercial

Overview

Oval Medical Technologies develops patient-centric autoinjectors designed to deliver high-viscosity or large-volume injectable drugs. The company has reported positive usability and performance results in comparative studies versus other market devices, with several major pharmaceutical companies conducting feasibility studies using its technology. Its ArQ – Bios platform is highlighted as flexible and suitable for challenging formulations.

Therapeutic areas: Other
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Several large pharmaceutical companies have conducted feasibility studies with the company's technology; SMC Ltd. is both parent and key manufacturing/service partner

Beyond the preview

Go deeper on Ovalt.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovalt.

Explore the full profile